MSC2156119J
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MSC2156119J, covering 2016-12-07 to 2019-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma [Phase 1, Phase 2]